The Heads of HTA Agencies is an independent group of 32 European healthcare agencies working together to advance strategic collaboration on HTA.
The Heads of HTA Agencies Group support the development of the basis for joint work on all HTA activities at EU level within the model of EU cooperation anticipated by the Regulation on HTA (HTAR).
The Heads of HTA Agencies Group support the preparation of national systems and capacities for the adoption of the HTA Regulation.
The Heads of HTA Agencies Group support the joint work performed at the technical and scientific level by HTA bodies across Europe.
The Heads of HTA Agencies Group advise policy makers and relevant EU and national institutions on matters regarding HTA, particularly cooperation in HTA.
Latest news
The HAG welcomes the adoption of implementing regulations concerning the rules for cooperation with the European Medicines Agency (EMA) and rules for the management of conflicts of interest
The Heads of Health Technology Assessment Agencies Group (HAG) warmly welcomes the adoption by the European Commission, in October 2024, of two critical implementing regulations
HAG members discuss the national implementation of the HTAR and reflect on the future actions
The Heads of HTA Agencies Group (HAG) met in Rome on October 24th. for their eight face-to-face encounter. The meeting, with more than 70 participants
HTA Regulation first implementing regulation adopted
The European Comission adopted the first implementing regulation ((EU) 2024/1381) pursuant to the HTA Regulation ((EU) 2021/2282). The implementing regulation sets new rules for the
HAG focuses on Joint Clinical Assessment and next steps of HTAR in its eighth meeting
Members of the Heads of HTA Agencies Group reunited on 16 and 17 April for their ninth meeting since the Group was setup in September
EU Commission launches the first public consultation on Health Technology Assessment (HTA) Implementing Regulation
The European Commission has just launched an online public consultation on the draft Implementing Act on Joint Clinical Assessments of Medicinal Products. The consultation is
HAG members discuss the national implementation of the HTAR and look on future developments including the EU Pharma Reform
Members of the Heads of HTA Agencies Group reunited virtually on 31 January for the 7th time. The meeting was hosted by INFARMED’s President and
